Callan JMB Inc., operating primarily through its subsidiary Coldchain Technology Services, LLC, specializes in providing temperature-controlled logistics solutions specifically for the life ...
Callan JMB Inc. (CJMB) is an integrative logistics and fulfillment provider focused on the life sciences and other critical, time- and temperature-sensitive industries. Through its subsidiary Coldchain Technology Services, LLC, the company is positioned to help customers move and preserve valuable biological and medical materials by using controlled logistics and ...Callan JMB Inc. (CJMB) is an integrative logistics and fulfillment provider focused on the life sciences and other critical, time- and temperature-sensitive industries. Through its subsidiary Coldchain Technology Services, LLC, the company is positioned to help customers move and preserve valuable biological and medical materials by using controlled logistics and specialized packaging approaches.
From a business perspective, Callan JMB serves a demanding customer base—pharmaceutical and biotech companies that must protect product integrity across shipping and storage windows. The company’s core offer centers on temperature-controlled logistics with particular emphasis on frozen shipping capabilities. This operational model is designed to support end-to-end handling of sensitive commodities such as personalized medicines, cell-based therapies, stem cells, cell lines, vaccines, diagnostic samples, reproductive materials, cord blood, organs, biopharmaceutical products, and infectious substances. In addition to pharmaceutical shipments, the company provides packaging services for other perishable (non-pharmaceutical) client goods, reflecting a broader cold-chain and perishable logistics competency.
Product and service-wise, Callan JMB combines physical logistics with packaging and technical support. Specialty packaging is a key element because it directly affects cold-chain performance (e.g., maintaining temperature ranges, protecting packaging integrity, and enabling compliant handling). The company also emphasizes emergency preparedness and response capabilities, suggesting readiness and operational procedures tailored for urgent or high-stakes distributions—an important differentiator for healthcare systems, public agencies, and pharmaceutical supply-chain continuity needs.
In terms of cost and BOM considerations, temperature-controlled logistics typically requires materials and labor that may include insulated shippers, cold/thermal components, monitoring/handling processes, and compliance-oriented packaging workflows. While exact bill-of-material (BOM) costs are not provided in the supplied data, Callan JMB’s service mix implies that these packaging and logistics inputs are integral to delivery performance and customer outcomes.
Financially, the publicly shared metrics available in the provided dataset indicate a relatively small company with a modest market capitalization and revenue scale (the firm is described as having full-time employees in the tens of people and is also described elsewhere as having a larger workforce range). The operational focus on specialized fulfillment can involve front-line staffing, warehouse and cold-chain infrastructure, and packaging execution costs. Management leadership is led by founder and CEO Wayne Williams, who has been associated with the company’s executive leadership role.
Key people and governance are anchored by Wayne Williams (founder, CEO, and President). Operational expansion and facility initiatives have also been discussed in related materials (e.g., new complex launches intended to capture pharmaceutical onshoring demand). Overall, Callan JMB’s “critical logistics” positioning targets customers who cannot compromise on product stability, documentation, packaging quality, and delivery timing—requirements that are especially pronounced in life sciences and emergency preparedness scenarios.
YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength.
QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes.
RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three).
$5.7M
-12.8%
+24.4%
Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day.
$-8.0M
-247.3%
+61.7%
Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials.
+36.8%
-5.8%
+42.6%
Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on).
-113.4%
-227.3%
+36.4%
Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales.
-139.2%
-298.3%
+69.2%
Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock.
$-5.2M
-1144.9%
+74.9%
FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine.
-90.2%
-1298.3%
+79.8%
Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe.
86.0%
+200.7%
+124.4%
Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking.
2.16x
-16.5%
-35.0%
Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground.
